CHINA MEDICAL SYSTEM HOLDINGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.2 HKD | +1.84% |
|
+2.86% | -47.98% |
| Apr. 23 | China Medical System's Anti-Anaemia NDA Accepted in China | MT |
| Apr. 23 | China Medical System Holdings Limited Announces New Drug Application of Desidustat Tablets Accepted in China | CI |
ETFs positioned on China Medical System Holdings Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.82% | 4 M€ | -27.92% | ||
| 0.84% | 2 M€ | -16.59% | - | |
| 0.44% | 2 M€ | -14.14% | ||
| 0.27% | 3 M€ | -0.84% | - | |
| 0.26% | 12 M€ | -16.71% | - | |
| 0.22% | 4 M€ | -11.56% | ||
| 0.18% | 11 M€ | +1.79% | ||
| 0.07% | 3 M€ | -.--% | - | |
| 0.07% | 1 M€ | +3.49% | - | |
| 0.03% | 441 M€ | +4.60% | - | |
| 0.03% | 149 M€ | +2.17% | - | |
| 0.03% | 2,808 M€ | +5.90% | - | |
| 0.03% | 4 M€ | -4.41% | - | |
| 0.03% | 117 M€ | +1.11% | - | |
| 0.01% | 7 M€ | +0.11% | - | |
| 0.01% | 31 M€ | +3.50% | - | |
| 0.00% | 34 M€ | +2.14% | - | |
| 0.00% | 7 M€ | +1.95% | - | |
| 0.00% | 147 M€ | +4.88% | - | |
| 0.00% | 389 M€ | +6.83% | - | |
| 0.00% | 34 M€ | +6.71% | - | |
| 0.00% | 39 M€ | +3.67% | - | |
| 0.00% | 302 M€ | +3.80% | - | |
| 0.00% | 15 M€ | +11.24% |
China Medical System Holdings Ltd is an investment holding company principally engaged in the production of medicines, as well as marketing, promotion and sales of drugs. The Company's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Final dividend
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
6.665
CNY
Average target price
10.08
CNY
Spread / Average Target
+51.30%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -47.98% | 2.24B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 867 Stock
- Funds and ETFs China Medical System Holdings Limited
